@Pharmafield profile picture
Pf Media @Pharmafield
Joined April 2009
  • Tweets 13,530
  • Following 1,352
  • Followers 2,061
4,179 Photos and videos
Pinned Tweet
Pf Media@Pharmafield
15 Mar 2022
The Spring issue of Pf Magazine is out now, with a look at what the future holds for #pharma. Now that digital relationships have been built, how do we make them sustainable? And how do we keep them relevant? bit.ly/3q55bkY
1
New MHRA Chief Executive Officer appointed - Pf Media bit.ly/3F2F2O6

New MHRA Chief Executive Officer appointed   - Pf Media

The government has announced the appointment of Lawrence Tallon as the new Chief Executive Officer of the MHRA.

pf-media.co.uk
45
Pf Media@Pharmafield
19 Jun 2024
The impact of EU pharmaceutical reform - Pf Media bit.ly/3KQBWMQ

The impact of EU pharmaceutical reform - Pf Media

The conversation around the proposed EU pharmaceutical legislation and incoming HTA reform was held against the backdrop of the EU elections.

pf-media.co.uk
73
Go-to-market innovation in 2028: Essential disruption dimensions for thriving in the new European healthcare landscape - Pf Media bit.ly/3RcqP4s

Go-to-market innovation in 2028: Essential disruption dimensions for thriving in the new European...

The European healthcare market is poised for significant disruption, with evolving consumer demands and new competitive forces.

pf-media.co.uk
52
Go-to-market innovation in 2028: Essential disruption dimensions for thriving in the new European healthcare landscape - Pf Media bit.ly/3Vw2Mjm
48
Pf Media@Pharmafield
15 May 2024
Dare to be disruptive – how to model your European go to market strategy for success  - Pf Media bit.ly/3ytkpat

Dare to be disruptive – how to model your European go to market strategy for success  - Pf Media

Nick Bartlett, Head of Consulting at Uniphar, shares key takeaways from his workshop at Reuters Pharma 2024 in Barcelona.

pf-media.co.uk
37
Novartis' leukaemia treatment to be made available on the NHS - Pf Media bit.ly/44qLjvz
66
Pf Media@Pharmafield
25 Apr 2024
NICE recommends new Novartis treatment for brain tumours - Pf Media bit.ly/44hxqQu

NICE recommends new Novartis treatment for brain tumours - Pf Media

NICE recommends new Novartis treatment for children and young people in England and Wales, with an aggressive form of brain tumour.

pf-media.co.uk
57
Pf Media@Pharmafield
18 Apr 2024
Promising new treatment strategy for aggressive form of leukaemia - Pf Media bit.ly/4463eb5
40
Pf Media@Pharmafield
28 Mar 2024
Positive trial results for PharmNovo's pain management drug - Pf Media bit.ly/4ctCIMx

Positive trial results for PharmNovo's pain management drug - Pf Media

PharmNovo's trial from Phase I of its neuropathic pain management drug candidate has given positive results in the feedback.

pf-media.co.uk
33
Pf Media@Pharmafield
27 Mar 2024
Research uncovers how to target dormant breast cancer cells and prevent relapse - Pf Media bit.ly/3Tyle8T

Research uncovers how to target dormant breast cancer cells and prevent relapse - Pf Media

Scientists have discovered how breast cancer cells can ‘hibernate’ to avoid treatment and ‘wake up’ years later – causing a relapse.

pf-media.co.uk
37
Pf Media@Pharmafield
21 Mar 2024
HCP engagement solutions – being present isn’t enough - Pf Media bit.ly/4cthz4U

HCP engagement solutions – being present isn’t enough - Pf Media

Have you invested in digital engagement of HCPs? When it comes to engaging healthcare professionals online, being present isn’t enough.

pf-media.co.uk
1
34
Pf Media@Pharmafield
15 Mar 2024
Almirall expands pipeline to rare dermatological diseases - Pf Media: bit.ly/48VLPCv

Almirall expands pipeline to rare dermatological diseases - Pf Media

Almirall and Eloxx Pharmaceuticals have agreed an exclusive license agreement for the asset ZKN-013, in use for rare dermatological diseases.

pf-media.co.uk
31
Pf Media@Pharmafield
15 Mar 2024
SMC accepts AbbVie’s new Parkinson’s drug within NHS Scotland - Pf Media bit.ly/3TBz8Ix

SMC accepts AbbVie's new Parkinson's drug within NHS Scotland - Pf Media

The Scottish Medicines Consortium (SMC) has accepted AbbVie's new Parkinson's drug for restricted use within NHS Scotland.

pf-media.co.uk
25
Pf Media@Pharmafield
29 Feb 2024
NICE recommends Janssen’s rare disease treatment - Pf Media bit.ly/49TbGMl

NICE recommends Janssen’s rare disease treatment - Pf Media

The National Institute for Health and Care Excellence has recommended Janssen’s treatment for rare disease, amyloid light-chain amyloidosis.

pf-media.co.uk
84
Pf Media@Pharmafield
15 Feb 2024
Besins Healthcare appoints new General Manager - Pf Media bit.ly/3SD9T7b

Besins Healthcare appoints new General Manager - Pf Media

Besins Healthcare appoints new General Manager, Irina Spirieva, to lead their role to meet the unmet needs of men and women’s health.

pf-media.co.uk
1
31
MHRA licenses treatment option for rare autoimmune disease - Pf Media bit.ly/3HPljj8

MHRA licenses treatment option for rare autoimmune disease - Pf Media

The MHRA has licensed argenx UK's treatment option for Myasthenia Gravis, a rare and chronic autoimmune disease.

pf-media.co.uk
26
VPAG survey – have your say - Pf Media bit.ly/3SGTsrC
1
26
Pf Media@Pharmafield
12 Oct 2023
Kyowa Kirin to acquire Orchard Therapeutics   - Pf Media bit.ly/3PRGWDc
73
Pf Media@Pharmafield
21 Sep 2023
MHRA grants marketing authorisation for LEO’s dermatitis treatment - Pf Media bit.ly/3PuyHg8
47
Pf Media@Pharmafield
14 Sep 2023
First treatment for acute migraine recommended by NICE - Pf Media bit.ly/3PCUFib

First treatment for acute migraine recommended by NICE - Pf Media

NICE has published final draft guidance recommending Pfizer’s treatment option for migraine with or without aura in adults.

pf-media.co.uk
43
Load more